Nanoparticles Might Help Treat Cystic Fibrosis


The first nanotechnology-enabled gene delivery system capable of efficiently penetrating the hard-to-breach mucus barrier shielding human airway and lung tissue may have been discovered, with potential to one day develop an inhaled vehicle for delivery of targeted therapeutic genes which may be delivered directly to the lungs at levels sufficient to treat cystic fibrosis (CF), chronic obstructive pulmonary disease, asthma and other life-threatening lung diseases.

Learn more about this here:

Read the latest news on cystic fibrosis here: